Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 820 of 1,261

  1. US 8703791

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  2. US 8703735

    Antisense antiviral compounds and methods for treating a filovirus infection

    Sarepta Therapeutics, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  3. US 8703756

    Synthetic procedure and cancer treatment with cisplatin derivatives

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  4. US 8703751

    Androstenediol as an indicator for assessing estrogenicity

    The Regents of the University of California · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  5. US 8703115

    Methods for preparing conjugates

    Nektar Therapeutics · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  6. US 8703730

    Complement antagonists and uses thereof

    REGENESANCE B.V. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  7. US 8703096

    Beta-amyloid PET imaging agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  8. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  9. US 8703762

    Method of treating organophosphorous poisoning

    The United States of America as repr. by the Sec. of the Army, U.S. Army Med. Resr. Inst. of Chem. Defense · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  10. US 8703208

    Nanometer mesoporous silica-based xerogel styptic process and its preparing process and application

    East China University of Science and Technology · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  11. US 8703726

    Methods for treating prostate conditions

    PTC THERAPEUTICS, INC. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  12. US 8703727

    Nanotechnology formulation of poorly soluble compounds

    Aphios Corporation · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  13. US 8703136

    Complement inhibition for improved nerve regeneration

    REGENESANCE B.V. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  14. US 8703200

    Inhibition of neovascularization by cerium oxide nanoparticles

    The Board of Regents of the University of Oklahoma · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  15. CA 2883399

    REDUCTION AU MINIMUM DE DEPOTS LIPIDIQUES BIOLOGIQUES SUR DES LENTILLES DE CONTACT

    BAUSCH & LOMB [US] · Granted Apr 17, 2014 · Expires Apr 12, 2034

    granted

  16. US 8697874

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  17. US 8697744

    Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  18. US 8697865

    Cyclic amide derivative, and its production and use

    Takeda Pharmaceutical Company Limited · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  19. US 8697858

    Antisense antiviral compound and method for treating influenza viral infection

    Sarepta Therapeutics, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  20. US 8697853

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  21. US 8697848

    Method for reducing immunogenicity of therapeutic protein compositions

    The Regents of the University of Colorado · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  22. US 8697709

    Fused ring heteroaryl kinase inhibitors

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  23. US 8697704

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  24. US 8697730

    5-lipoxygenase activating protein (FLAP) inhibitor

    Panmira Pharmaceuticals, LLC · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.